| 前收市價 | 0.7600 |
| 開市 | 0.8700 |
| 買盤 | 0.0000 |
| 賣出價 | 0.0000 |
| 拍板 | 1.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 0.7300 - 0.8700 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 799 |
ZacksPacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
ZacksPacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0.08%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksSoft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings
Despite strength in Revio and Onso platforms, an increasing number of customers delaying instrument purchases is likely to have dampened PacBio's (PACB) top line in the first quarter.
